Search details
1.
Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study.
Cancer
; 130(8): 1281-1291, 2024 Apr 15.
Article
in English
| MEDLINE | ID: mdl-38261521
2.
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
N Engl J Med
; 384(14): 1289-1300, 2021 04 08.
Article
in English
| MEDLINE | ID: mdl-33616314
3.
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Lancet Oncol
; 24(3): 228-238, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36858721
4.
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(12): 1399-1410, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38039993
5.
Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study.
Lancet Oncol
; 23(6): 768-780, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35489363
6.
Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale.
Future Oncol
; 15(9): 929-941, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-30689402
7.
Benzodiazepines and Development of Delirium in Critically Ill Children: Estimating the Causal Effect.
Crit Care Med
; 46(9): 1486-1491, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29727363
8.
Validation of the Survey of Sleep Quality in the Pediatric Intensive Care Unit (SSqPICU).
J Clin Sleep Med
; 2024 Mar 08.
Article
in English
| MEDLINE | ID: mdl-38456806
9.
More Than Skin Deep: Lethargy and Diaphoresis in the Morning.
Pediatr Emerg Care
; 34(12): e246-e250, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30507758
10.
Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.
Cardiovasc Intervent Radiol
; 45(4): 405-412, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35119481
11.
Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
Lancet Gastroenterol Hepatol
; 6(8): 649-658, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34087115
12.
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT.
J Gastroenterol
; 56(6): 570-580, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33948712
13.
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma.
J Clin Oncol
; 38(26): 2960-2970, 2020 09 10.
Article
in English
| MEDLINE | ID: mdl-32716739
Results
1 -
13
de 13
1
Next >
>>